TRPV4 expression level was negatively correlated with prognosis in patients with all grades of glioma and glioblastoma multiforme thus, we concluded that TRPV4 could be a biomarker and prognostic factor for glioblastoma patients. This evidence concerns the gene TRPV4 and central nervous system cancer.